Efficacy and Safety of ChOline ALfoscerate in Patient With Mild to Moderate Alzheimer's Disease

NCT05383183 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

630

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: Choline Alfoscerate 400mg
DRUG: Placebo

Sponsor

Daewoong Bio Inc.